Calcium channel blocker nasal spray treats paroxysmal supraventricular tachycardia

20260 citationsJournal Article

Authors

Diane S. Aschenbrenner · Johns Hopkins University

Abstract

The calcium channel blocker etripamil (Cardamyst), a nasal spray, has been approved for treatment of periodic paroxysmal supraventricular tachycardia (PSVT). Nurses should teach patients to treat symptoms of PSVT with etripamil immediately, and how to administer the nasal spray dosage.

Topics & Keywords

Cardiac Arrhythmias and Treatments Cardiac Arrest and Resuscitation Pathogenesis and Treatment of Hiccups

Publication Details

Published in: AJN American Journal of Nursing

Volume 126, Issue 4, pp. 24-25

DOI: 10.1097/ajn.0000000000000276a

Field-Weighted Citation Impact: 0.00

Command Palette

Calcium channel blocker nasal spray treats paroxysmal supraventricular tachycardia

Authors

Abstract

Topics & Keywords

Publication Details